Categories Earnings, Technology

Facebook mulling purchase of British AI firm Bloomsbury

Facebook (FB) is planning to buy British AI start-up Bloomsbury AI in an expected cash-and-stock deal that could be worth around $30 million. Bloomsbury is a three-year old company that specializes in natural language tools and is the developer of a product named Cape, which can read text documents and answer questions on their content.

Facebook is considering this purchase as part of its efforts to tackle fake news and other issues with the content on its website. The company recently announced that it would add more human editors and improve its AI capabilities to rectify the problems related to its content. Its efforts included the global expansion of fact-checking resources to more regions.

Special treatment on user data

Meanwhile, following the Cambridge Analytica scandal and the issue of user data privacy, more revelations keep coming out. Documents handed over to US lawmakers indicate that Facebook granted 61 companies including Nike, Audi, Panasonic and Oracle a special extension to continue accessing user data.

After introducing changes to its rules regarding access to user data by apps in April 2014, Facebook set a compliance deadline of May 2015 for most apps. However these companies were given an extension of around six months after May to comply with the rules.

Facebook also said it granted relaxations to 52 technology firms like Apple, Amazon and Microsoft in order to help them make the necessary changes so that Facebook was easily accessible on their devices. These included Chinese companies like Alibaba too, which have raised security concerns.

Facebook said it ended the majority of these partnerships while some more are set to be terminated between July and October. A few more partnerships will continue beyond this timeframe.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top